Pharynx Cancer Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Pharynx Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 28 trials

Recruiting
Phase 1Phase 2

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Cervical CancerAnal CancerPenile Cancer+14 more
Christian Hinrichs15 enrolled2 locationsNCT05639972
Recruiting
Phase 2

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Cervical CancerMetastatic CancerAnal Cancer+18 more
Christian Hinrichs20 enrolled3 locationsNCT05686226
Recruiting
Not Applicable

Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx

Oropharynx Cancer
Duke University120 enrolled2 locationsNCT04667585
Recruiting

Microbiome in Head and Neck Squamous Cell Carcinoma

Head and Neck CancerOral CancerLip Cancer+1 more
University of Colorado, Denver60 enrolled1 locationNCT05837221
Recruiting
Phase 2

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

Squamous Cell Carcinoma of Head and NeckOral Cavity CancerNasal Cavity Cancer+9 more
Memorial Sloan Kettering Cancer Center40 enrolled7 locationsNCT07063212
Recruiting
Not Applicable

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

Oropharynx Cancer
The Institute of Molecular and Translational Medicine, Czech Republic20,000 enrolled5 locationsNCT07033091
Recruiting
Not Applicable

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

Head and Neck CancerHead and Neck Squamous Cell CarcinomaOral Cavity Cancer+2 more
Medical University of South Carolina532 enrolled4 locationsNCT05793151
Recruiting
Phase 3

Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma

Oropharynx CancerLarynx CancerHypopharynx Cancer+1 more
Centre Leon Berard460 enrolled7 locationsNCT06706401
Recruiting
Phase 2

Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma

Oropharynx Cancer
University of Zurich120 enrolled5 locationsNCT06563362
Recruiting
Phase 2

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

Head and Neck CancerHead and Neck Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma+2 more
University of Maryland, Baltimore61 enrolled5 locationsNCT06088381
Recruiting
Phase 2

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

HPV-Related MalignancyHPV-Related CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma+2 more
Memorial Sloan Kettering Cancer Center30 enrolled8 locationsNCT05307939
Recruiting
Not Applicable

Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae

Head and Neck CancerOral Cavity CancerOropharynx Cancer
Institut Claudius Regaud40 enrolled4 locationsNCT05757817
Recruiting
Phase 2

Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)

Oropharynx Cancer
University of California, San Diego29 enrolled3 locationsNCT05787639
Recruiting
Phase 2

Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Oropharynx Cancer
Heath Skinner150 enrolled1 locationNCT05388773
Recruiting
Not Applicable

Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly

Oropharynx CancerFrailty
Omar Mahmoud20 enrolled1 locationNCT06309225
Recruiting
Phase 3

Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

Head and Neck CancerOropharynx CancerHuman Papilloma Virus
Centre hospitalier de l'Université de Montréal (CHUM)360 enrolled2 locationsNCT04178174
Recruiting

Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy

HNSCCOral Cavity CancerOropharynx Cancer+2 more
University Hospital Freiburg1,500 enrolled18 locationsNCT05337631
Recruiting
Not Applicable

De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers

Oropharynx Cancer
Georgetown University30 enrolled1 locationNCT06554158
Recruiting
Phase 2

Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer

Oropharynx Cancer
Fox Chase Cancer Center22 enrolled1 locationNCT05800574
Recruiting

Arabic PRO Measures for Head and Neck Cancer Radiotherapy.

Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Neoplasms+5 more
King Saud University125 enrolled1 locationNCT06662929